Sprouts is locked in a sustained, punishing downtrend, with the stock down 41.55% over the past year versus a 15.53% gain for the S&P 500, a relative-strength gap of -57.08 percentage points. At $65.20, the shares sit just 5.4% above the 52-week low of $61.88 and a staggering 42.5% below the 52-week high of $113.49, placing the price at roughly 12.6% of its 52-week range. That positioning near the bottom of the range signals persistent distribution and a falling-knife profile rather than a clean value entry, even as the -54.63% max drawdown underscores how severe the de-rating has been. Short-term momentum remains negative and confirms the longer-term weakness rather than diverging from it: the stock is down 8.25% over the past month and 13.96% over three months, against a 1.22% gain and 2.69% gain for SPY over the same windows, producing relative-strength readings of -9.47 and -16.65. The year-to-date decline of 19.15% is milder than the 12-month figure, implying the worst damage occurred in the back half of the prior year, but the recent leg lower shows no stabilization. Volume of roughly 2.04 million shares and a short ratio of 6.41 days-to-cover suggest meaningful bearish positioning that could fuel sharp squeezes on any positive catalyst, consistent with the violent single-day rallies visible in the price history. Key technical levels are well defined: support rests at the 52-week low of $61.88, and a decisive break below would open fresh downside and confirm the downtrend's continuation, while resistance sits at the $113.49 high, with intermediate supply likely near the $80-$90 zone where the stock repeatedly failed in mid-2026. A beta of 0.665 indicates the stock is roughly one-third less volatile than the market on a systematic basis, which argues for smaller position-sizing adjustments for market risk but offers little protection against the stock-specific de-rating that has driven the drawdown. A reclaim of the $70-$75 area would be the first sign of a bottoming base, while a breakout above $90 would be needed to credibly challenge the downtrend.

Revenue growth has decelerated to a low-single-digit pace: Q2 2026 revenue of $2.326 billion grew just 4.74% year over year, a marked slowdown from the roughly 14.1% implied by Q2 2025's $2.221 billion versus Q2 2024's $1.946 billion. The sequential trend is flattening, with Q1 2026 revenue of $2.329 billion essentially matching Q2 and growing only 4.1% over Q1 2025's $2.236 billion, while Q4 2025's $2.149 billion rose 7.6% over the prior-year quarter. The segment mix is stable, with perishables at $1.330 billion (57.2% of the $2.326 billion total) and non-perishables at $996 million, meaning the fresh-produce core remains the primary growth engine and any traffic softness hits the largest line directly. The deceleration from double-digit to mid-single-digit growth is the crux of the bear case and explains much of the multiple compression, though the still-positive trajectory supports a modest store-expansion story. Profitability remains solid but is compressing: Q2 2026 net income of $129.2 million on a 5.55% net margin compares unfavorably with Q2 2025's $133.7 million and 6.02% margin, and gross margin slipped to 38.72% from 37.20% a year earlier while operating margin fell to 7.49% from 8.14%. The sequential deterioration is more pronounced, with Q1 2026's 7.03% net margin and 9.29% operating margin down sharply from Q1 2025's 8.05% and 10.20%, reflecting SG&A leverage turning negative as sales growth slows. Gross margin in the high-30s is respectable for grocery retail, but the direction of travel matters: four consecutive quarters of year-over-year operating-margin decline point to cost inflation and promotional intensity that the top line is no longer offsetting. The balance sheet is serviceable but not fortress-like: debt-to-equity of 1.385 and a current ratio of 0.930 (below 1.0) indicate reliance on short-term liabilities and lease-heavy financing typical of retailers, while interest coverage remains enormous at over 2,500x given minimal interest expense. Cash generation is the bright spot, with trailing free cash flow of $355.2 million and Q2 2026 operating cash flow of $133.7 million against capex of $88.8 million, though the $44.95 million quarterly FCF was pressured by a $91.9 million working-capital drag. ROE of 37.3% is impressive but flattered by leverage and buybacks, and the company returned capital aggressively with $70.0 million repurchased in Q2 and $140.0 million in Q1, signaling confidence but also reducing the cash buffer to $226.5 million.